Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02279381
Other study ID # 3106-Ped-ERC-14
Secondary ID
Status Completed
Phase Phase 4
First received October 28, 2014
Last updated June 8, 2016
Start date November 2014
Est. completion date November 2015

Study information

Verified date June 2016
Source Aga Khan University
Contact n/a
Is FDA regulated No
Health authority Pakistan: Ministry of Health
Study type Interventional

Clinical Trial Summary

Neonatal mortality has been a notable health issue in Pakistan. Considering the importance of the issue and well recognized interventions the investigators are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, Kangaroo Mother Care (KMC) and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and essential neonatal care alone. The investigators anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.


Description:

The global neonatal mortality burden is one of the imminent factors which derail the achievement of the MDG 4 in many developing countries including Pakistan. Four million infants infants die in their first 28 days of their lives which account for about 40% of the total under-five mortality. The burden of neonatal mortality in Pakistan is alarming as the current neonatal mortality rate (NMR) is 55 per 1000 live births, third worst in the world. The major causes of these deaths are infections, preterm births and birth asphyxia which are avoidable. Despite many initiatives the NMR remains unchanged since last decade in Pakistan.

Literature shows that low cost facility and community based interventions can reduce NMR significantly. Early neonatal care, application of chlorhexidine for cord care and Kangaroo Mother Care (KMC) have been recognized as effective intervention in reduction of neonatal morbidity and subsequently neonatal mortality in many developing countries. However these interventions have never been tested as a package and data about their combined effect is scarce both in Pakistan and developing countries.

Considering the importance of the issue and well recognized interventions we are proposing a randomized controlled trial in a rural district of Pakistan which will evaluate the effectiveness of a neonatal package comprised of the standard neonatal care, KMC and application of chlorhexidine compared with standard neonatal care coupled with application of chlorhexidine and standard neonatal care alone. We anticipate that this study will provide an evidence base way forward benefiting the children of Pakistan.


Recruitment information / eligibility

Status Completed
Enrollment 1450
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 28 Days
Eligibility Inclusion Criteria:

- All healthy newborns born in the study settings will be systematically enrolled in the trial after prior consent.

Exclusion Criteria:

- Infants with congenital/birth defects,

- any localized infection on the peri umbilical region at the time of birth or application of

- any other material such as dung etc before enrollment on the cord.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
Chlorhexidine
4% chlorhexidine will be applied to the umbilical stump from day 1 to day 10
Other:
Kangaroo Mother Care
Skin to Skin Care which is Kangaroo mother care will be carried out by mother from Day 1 till the study completion
Essential Neonatal Care
Essential Neonatal Care ensures delayed bathing, use of colostrum, exclusive breast feeding, skin to skin care for hypothermia, dry cord care, eye care and immunization for the newborn

Locations

Country Name City State
Pakistan Taluka Hospital KN Shah Dadu Sindh

Sponsors (3)

Lead Sponsor Collaborator
Aga Khan University The International Federation of Red Cross and Red Crescent Societies, University of Sydney

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction in the Incidence of Neonatal infections in the first 28 days of life (Clinical presence of danger signs as per the IMNCI guidelines.) Clinical presence of danger signs as per the IMNCI guidelines. 28 days post recruitment Yes
Secondary Reduction in the Incidence of omphalitis (Redness and Swelling of umbilical stump/cord (Inflammation)) Redness and Swelling of umbilical stump/cord (Inflammation): 28 days post recruitment Yes
Secondary Failure to thrive (Weight, length and OFC appropriate for age as per WHO guidelines) Weight, length and OFC appropriate for age as per WHO guidelines 28 days post recruitment Yes
Secondary Utilization of KMC Compliance, Frequency and duration Compliance, Frequency and duration - hours/day 28 days post recruitment Yes
See also
  Status Clinical Trial Phase
Completed NCT00920530 - Real-Time PCR for the Detection of Vaginal Group B Streptococcus Carriage: a Medico-Economic Study N/A
Completed NCT00743691 - Impact Study of Community Based Treatment of Neonatal Infection by Health Extension Workers on Neonatal Mortality N/A
Terminated NCT01214473 - Probiotics for Prevention Neonatal Infection N/A
Completed NCT00713726 - Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants Phase 3